1. Skip to content

Mesothelioma Cancer Resources Blog

  • Mesothelioma Treatment Drug Enters Phase I/II Trial

    Oxford BioMedica and a team of cancer immunologists from Cardiff University in Great Britain are collaborating to evaluate TroVax in a Phase I/II study for mesothelioma.  The study aims to examine the effect of TroVax in combination with first-line chemotherapy agents Alimta and cisplatin as a treatment against malignant mesothelioma. Mesothelioma is a rare, aggressive …

    Label: Clinical Trial Research News

    Posted on Tuesday, Jun 29, 2010
  • In-Home Hospice Care for Mesothelioma Patients

    One of the tragic facts of mesothelioma is that once diagnosed the average survival time is from 4-18 months.  While it can be treated with varying degrees of success through the use of surgical procedures, chemotherapy and radiation, there is still no known cure. When a mesothelioma patient no longer responds to a prescribed treatment …

    Label: Mesothelioma Treatments

    Posted on Monday, Jun 28, 2010
  • Court Rules U.S. Navy Partially Responsible in Mesothelioma Case

    After a California jury found 17 defendants liable for the death of Ulysses Collins, who died in 2005 from mesothelioma, a California appeals court has added the United States Navy to the list holding them responsible for a portion of the award.  Collins was exposed to asbestos and asbestos-containing products throughout his career as a …

    Label: Mesothelioma

    Posted on Friday, Jun 25, 2010
Load More News